RE:RE:RE:6 months and a bit …100% Misinformation correction
81% done ( 170+90 / 170+ 150) Phase 3b results amalgamated with Phase 3
that's without considering JK's latest paper which, based on good Tigris results means in theory it could already be statistically a "done deal"
further tranches of $ could delay / reduce the need for much more dilution ( see Baxter tranche 2 and warrants)
My best guess 350 M tops ( not great considering what might have been with proper promotion, but at leadt spread out over $2b USD plus revenue potential.)
Even if 150 needed for Tigris ( ie FDA insists) it may come under new ownership. Early 2025 at latest.
Rather than fret about delays - See also the runnup that occurred in the 6 months proceeding Ohase 3 results in 2016.
MM